Check pharmacology, toxicology and pharmaceutics papers: citations, claims and retractions

Improved Immunogenicity of Biodegradable Polymer Particles Entrapped Rotavirus Vaccine

Nayak, B., Ray, A. R., Panda, A. K., & Ray, P. (2011) · Journal of Biomaterials Applications

Advanced Drug Delivery SystemsViral gastroenteritis research and epidemiology

Cited by 10

Do Training Programs Work? An Assessment of Pharmacists Activities in the Field of Chemical Dependency

Brooks, V. G., Brock, T. P., & Ahn, J. (2001) · Journal of Drug Education

Pharmacy and Medical PracticesSubstance Abuse Treatment and Outcomes

Cited by 10

When Cofactors Aren’t X Factors: Functional Groups That Are Labile in Human Liver Microsomes in the Absence of NADPH

Landry, M. L., Trager, R., Broccatelli, F., & Crawford, J. J. (2022) · ACS Medicinal Chemistry Letters

Pharmacogenetics and Drug MetabolismComputational Drug Discovery Methods

Cited by 10

Fusion of nonclinical and clinical data to predict human drug safety

Johnson, D. E. (2013) · Expert Review of Clinical Pharmacology

Pharmacovigilance and Adverse Drug ReactionsAnimal testing and alternatives

Cited by 9

Neutralizing serum amyloid a protects against sinusoidal endothelial cell damage and platelet aggregation during acetaminophen-induced liver injury

You, K., Wang, Y., Chen, X., Yang, Z., Chen, Y., Tan, S., Tao, J., Getachew, A., Pan, T., Xu, Y., et al. (2023) · Biochemical and Biophysical Research Communications

Drug-Induced Hepatotoxicity and ProtectionLiver physiology and pathology

Cited by 9

Time-dependent inhibitory effects of (1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylvinyl-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(2-oxopropyl)-11,28-dioxa-4- azatricyclo[22.3.1.04.9]octacos-18-ene-2,3,10,16-tetrone (FK1706), a novel nonimmunosuppressive immunophilin ligand, on CYP3A4/5 activity in humans in vivo and in vitro

Minematsu, T., Lee, J., Zha, J., Moy, S., Kowalski, D., Hori, K., Ishibashi, K., Usui, T., & Kamimura, H. (2010) · Drug Metabolism and Disposition

Pharmacogenetics and Drug MetabolismSignaling Pathways in Disease

Cited by 9

Effects of methimazole on the elimination of irinotecan

van der Bol, J. M., Visser, T. J., Loos, W. J., de Jong, F. A., Wiemer, E. A. C., van Aken, M. O., Planting, A. S., Schellens, J. H., Verweij, J., & Mathijssen, R. H. J. (2011) · Cancer Chemotherapy and Pharmacology

Pharmacogenetics and Drug MetabolismCancer therapeutics and mechanisms

Cited by 9

Psidium guajava leaf extract improves gastrointestinal functions in rats and rabbits: an implication for ulcer and diarrhoea management

Ibeh, L. N., Ijioma, S. N., Emmanuel, O., Timothy, C. O., & Ugbogu, E. A. (2021) · Biomarkers

Psidium guajava Extracts and ApplicationsMedicinal Plant Research

Cited by 9

UniTox: Leveraging LLMs to Curate a Unified Dataset of Drug-Induced Toxicity from FDA Labels

Silberg, J., Swanson, K., Simon, E., Zhang, A., Ghazizadeh, Z., Ogden, S., Hamadeh, H., & Zou, J. (2024) · neural information processing systems

Pharmacovigilance and Adverse Drug ReactionsBiomedical Text Mining and Ontologies

Cited by 9

Concentrations of phenobarbital, flurazepam, and flurazepam metabolites in autopsy cases

Ferrara, S., Tedeschi, L., Marigo, M., & Castagna, F. (1979) · Journal of Forensic Sciences

Forensic Toxicology and Drug AnalysisHistorical and Scientific Studies

Cited by 9

Evaluation of enzyme-linked immunosorbent assay screening kits for the detection of nitazene analogs

Pacana, A. L., & Skillman, B. N. (2025) · Journal of Forensic Sciences

Forensic Toxicology and Drug AnalysisPsychedelics and Drug Studies

Cited by 9

Characterization of Vibrio cholerae neuraminidase as an immunomodulator for novel formulation of oral allergy immunotherapy

Diesner, S. C., Bergmayr, C., Wang, X.-Y., Heiden, D., Exenberger, S., Roth-Walter, F., Starkl, P., Ret, D., Pali-Schöll, I., Gabor, F., et al. (2018) · Clinical Immunology

Advanced Drug Delivery SystemsAllergic Rhinitis and Sensitization

Cited by 9

Safety assessment of disulfiram: real-world adverse event analysis based on FAERS database

Luo, J., Zeng, Y., Chen, Z., Luo, Y., Shi, L., & Zhou, X. (2024) · Frontiers in Psychiatry

Pharmacovigilance and Adverse Drug ReactionsPharmaceutical Practices and Patient Outcomes

Cited by 9

Do pharmacy practice standards effectively describe behaviour? Reviewing practice standards using a behavioural specificity framework

Mill, D., Page, A., Johnson, J., Lee, K., Salter, S. M., Seubert, L., Clifford, R., & D’Lima, D. (2022) · BMC Health Services Research

Pharmacy and Medical PracticesClinical practice guidelines implementation

Cited by 9

Quantitative Cytochrome P450 3A4 Induction Risk Assessment Using Human Hepatocytes Complemented with Pregnane X Receptor-Activating Profiles

Ekiciler, A., Chen, W. L. K., Bo, Y., Pugliano, A., Donzelli, M., Parrott, N., & Umehara, K. (2023) · Drug Metabolism and Disposition

Pharmacogenetics and Drug MetabolismDrug Transport and Resistance Mechanisms

Cited by 9

Assessment of UDP-glucuronosyltransferase catalyzed formation of Picroside II glucuronide in microsomes of different species and recombinant UGTs

Li, T., Zheng, Y., Fu, F., Ji, H., Chen, X., Zhao, Y., Zhao, D., Li, N., & Zhang, L. (2011) · Xenobiotica

Pharmacogenetics and Drug MetabolismDrug Transport and Resistance Mechanisms

Cited by 9

Conflicts of interest and outcomes of clinical trials of antidepressants: An 18-year retrospective study

Waqas, A., Baig, A. A., Khalid, M. A., Aedma, K. K., & Naveed, S. (2019) · Journal of Psychiatric Research

Pharmaceutical industry and healthcareTreatment of Major Depression

Cited by 9

Association between industry support and the reporting of study outcomes in randomized clinical trials of dental implant research from the past 20 years

Dini, C., Pereira, M. M. A., Souza, J. G. S., Shibli, J. A., de Avila, E. D., & Barão, V. A. R. (2022) · Clinical Implant Dentistry and Related Research

Pharmaceutical industry and healthcareDental Implant Techniques and Outcomes

Cited by 9

Impact of Discordance Among Regulations for Biopharmaceutics Classification System-Based Waivers of Clinical Bioequivalence Studies

Cook, J. (2015) · Dissolution Technologies

Drug Solubulity and Delivery SystemsPharmaceutical studies and practices

Cited by 8

Activity-based detection of synthetic cannabinoid receptor agonists in plant materials

Timmerman, A., Balcaen, M., Coopman, V., Degreef, M., Pottie, E., & Stove, C. P. (2024) · Harm Reduction Journal

Forensic Toxicology and Drug AnalysisCannabis and Cannabinoid Research

Cited by 8

Fentanyl-related deaths in Ontario, Canada: toxicological findings and circumstances of death in 4395 cases (2020–22)

Adamo, A., Marshall, K., & Woodall, K. L. (2024) · Journal of Analytical Toxicology

Forensic Toxicology and Drug AnalysisOpioid Use Disorder Treatment

Cited by 8

Enhanced dissolution of anticancer drug letrozole from mesoporous zeolite clinoptilolite

Kukobat, R., Škrbić, R., Vallejos-Burgos, F., Mercadelli, E., Gardini, D., Silvestroni, L., Zanelli, C., Esposito, L., Stević, D., Atlagić, S. G., et al. (2024) · Journal of Colloid and Interface Science

Drug Solubulity and Delivery SystemsZeolite Catalysis and Synthesis

Cited by 8

A novel screening workflow for nitazene analogs using LC–MS/MS precursor ion scan acquisition

Pacana, A. L., & Skillman, B. N. (2025) · Journal of Analytical Toxicology

Forensic Toxicology and Drug AnalysisAnalytical Methods in Pharmaceuticals

Cited by 8

Non-fatal opioid overdose associated predominantly with the benzimidazolone, cychlorphine

Sprague, J. E., Toms, J. A., & Ratermann, C. F. (2026) · Clinical Toxicology

Forensic Toxicology and Drug AnalysisOpioid Use Disorder Treatment

Cited by 8